Boston University Libraries OpenBU
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    •   OpenBU
    • Theses & Dissertations
    • Boston University Theses & Dissertations
    • View Item
    •   OpenBU
    • Theses & Dissertations
    • Boston University Theses & Dissertations
    • View Item

    Investigation of novel tissue biomarkers for the study of melanoma progression

    Thumbnail
    Date Issued
    2013
    Author(s)
    Shah, Pinkey
    Share to FacebookShare to TwitterShare by Email
    Export Citation
    Download to BibTex
    Download to EndNote/RefMan (RIS)
    Metadata
    Show full item record
    Permanent Link
    https://hdl.handle.net/2144/12220
    Abstract
    Melanoma is the least common of skin cancers but is the most aggressive subset. Arising from the melanocytes found in the epidermal-dermal junction of the skin, the disease has frequently been linked to increased exposure to UV irradiation in addition to significant genetic influences. Melanoma can be cured with surgical intervention if the lesion is detected at an early stage. However, prognosis is poor after melanoma has metastasized to other organs and there are few treatment options available outside of chemotherapy. Little is known about the molecular basis for the biological behavior of melanoma, making its clinical course somewhat unpredictable and rational treatment prioritization extremely difficult. Biomarkers are prognostic factors that mimic the biological tendencies of a tumor. They can be physical markers or molecular fingerprints. Identification of biomarkers in melanoma will allow clinicians and researchers to better predict the behavior of melanocytic tumors, thus allowing for a more optimal prioritization of treatment for each individual affected by this disease. Much research has gone into developing biomarkers related to genetic alterations associated with melanoma onset and progression; however independent confirmatory tests or data from clinical trials are still needed to validate the research. Recent studies have explored the relationship between cancer and the host’s immune response. Cancer cells are known to secrete cytokines and growth factors that influence its own aggressiveness. Moreover, the discovery of tumor associated antigens serve as more evidence that there is an immune response to cancer and hold promising clinical therapies for the future. [TRUNCATED]
    Description
    Thesis (M.A.)--Boston University
    Collections
    • Boston University Theses & Dissertations [6982]


    Boston University
    Contact Us | Send Feedback | Help
     

     

    Browse

    All of OpenBUCommunities & CollectionsIssue DateAuthorsTitlesSubjectsThis CollectionIssue DateAuthorsTitlesSubjects

    Deposit Materials

    LoginNon-BU Registration

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Boston University
    Contact Us | Send Feedback | Help